Chinook Therapeutics, Inc. Email Format
Biotechnology ResearchWashington, United States201-500 Employees
Chinook Therapeutics, Inc. is a biotechnology research company based in Seattle, Washington. It focuses on developing therapies for patients with rare kidney diseases. The organization recently formalized a combination with Novartis to broaden its scientific capabilities and expand treatments in this therapeutic area. The acquisition places Chinook within Novartis’ broader biopharmaceutical ecosystem, linking its nephrology-focused research with a larger global organization. Based in Seattle, the company has a workforce in the hundreds.